Institutes outside Greece
Evaluation der Hämostase mittels Rotationsthrombelastometrie (ROTEM®) bei Patienten mit akutem Leberversagen und fortgeschrittener Lebererkrankung
Abstract
dc:descriptionLiver diseases, such as acute liver failure and liver cirrhosis, are characterized by complex coagulation disorders. Conventional coagulation tests, such as International Normalized Ratio (INR), activated Partial Thromboplastin Time, platelet counts and fibrinogen, show an increased bleeding diathesis. However, patients with progressive liver diseases may develop thrombotic complications with partially fatal consequences. Despite this evidence, coagulation management and supplementation of missing coagulation factors prior invasive procedures is currently based on these conventional coagulation tests. Rotational thrombelastometry (ROTEM®) is a bedside coagulation test, which provides a global assessment of hemostasis in real-time. This study included patients with acute liver failure or liver cirrhosis, who had abnormal coagulation parameters according to conventional coagulation tests. Evaluation of hemostasis and substitution of missing coagulation factors prior interventions was based on ROTEM®-analysis and on a ROTEM®-based transfusion algorithm. Patients with acute liver failure exhibited in ROTEM®-analysis a typical coagulation profile in comparison to patients with liver cirrhosis. This observation is of great importance and may contribute to the distinction between these two entities. Based on ROTEM®-analysis, there was no substitution of coagulation factors required prior interventions in patients with acute liver failure. Patients with liver cirrhosis and INR > 1,5 received after ROTEM®-analysis more fibrinogen and less prothrombin complex concentrates (PPSB) in comparison to control group. Additionally, substitution of Fresh Frozen Plasma (FFP) was completely avoided. Furthermore, patients with liver cirrhosis received based on ROTEM® significantly less platelet concentrates. Taken together, ROTEM®-based coagulation management significantly reduced supplementation of coagulation factors prior interventions compared to conventional methods. This approach was not associated with an increase in bleeding complications. Moreover, there was a significant reduction in costs as well as in transfusion-associated complications.
Degree
thesis:*- Grantor dc:publisher
- Institutes outside Greece
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Bedreli, Sotiria
- Μπέδρελη, Σωτηρία
Subjects
dc:subject × 14Rights
- Language dc:language
- ger
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/57518